Combimist-L CFC Free Inhaler
By Combimist-L
Rx
200mdi Inhaler in a Packet

Composition
Levosalbutamol(50mcg) + Ipratropium(20mcg)

Manufacturer - Zydus Cadila
Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Expires on or after
January, 2027

liver
Safety Advice - Liver When using Combimist-L CFC Free Inhaler, it is important to note that no interactions or connections have been identified specifically in relation to liver issues. However, it is always advisable to exercise caution and be aware of any potential impact on liver function while using this inhaler. Monitoring your liver health and seeking medical advice if you experience any unusual symptoms related to your liver is essential. If you have any concerns or questions regarding the use of Combimist-L CFC Free Inhaler and its effects on your liver, it is recommended to consult with your healthcare provider for personalized guidance.

kidney
It is important to note that no interactions have been found or established with the Combimist-L CFC Free Inhaler related to kidney issues. It is always recommended to consult with your doctor for proper guidance before using this inhaler.

alcohol
Combimist-L CFC Free Inhaler can make you very sleepy when used with alcohol.

driving
No interaction with driving found with Combimist-L CFC Free Inhaler. It's safe to drive while using this medication.

pregnancy
Combimist-L CFC Free Inhaler may not be safe to use during pregnancy. Limited human studies suggest potential harm to the baby. Your doctor will assess the risks and benefits before prescribing. Consult your doctor before using Combimist-L CFC Free Inhaler during pregnancy.

breastfeeding
Combimist-L CFC Free Inhaler is considered safe during breastfeeding based on limited human data indicating low risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹399.3
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024